Join
Live feed
·
PRReleasevia Quantisnow
Zymeworks Inc. logo
BeiGene Ltd. logo

Zymeworks Announces Expansion of Zanidatamab Pivotal Trial in HER2-Amplified Biliary Tract Cancer in Asia in Collaboration With BeiGene

ByQuantisnow·Wall Street's wire, on your screen.
ZYME· Zymeworks Inc.BGNE· BeiGene Ltd.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ZYME (Zymeworks Inc.), BGNE (BeiGene Ltd.) and more on Quantisnow.